Authority to Address Allocation of Dialysis and Other Scarce Resources

 

Bruce C. Vladeck

/kidneynews/4_10_11/23a/graphic/23af1.jpg

The controversial issues involved in the future allotment of health care resources will be the subject of the Christopher R. Blagg Endowed Lectureship in Renal Disease and Public Policy. An expert with broad experience with Medicare and other programs, Bruce C. Vladeck, PhD, will speak on Friday, Nov. 2, at 2 p.m. on “Allocation of Health Care: Dialysis and Beyond.”

Dr. Vladeck is a senior adviser to Nexera, Inc., a consulting subsidiary of the Greater New York Hospital Association, which he joined in 2009. His varied career has included senior leadership roles in the public, nonprofit, academic, and business communities. He is a widely recognized expert in health care policy and finance.

Dr. Vladeck was administrator of the Health Care Financing Administration (HCFA, the predecessor of the Centers for Medicare & Medicaid Services) from 1993 through 1997, a period that included the Clinton administration’s failed health care reform attempt, the Contract with America and switch to Republican control of Congress, budget stalemates, and the Balanced Budget Act of 1997.

Dr. Vladeck’s time at HCFA was marked by innovation in Medicaid programs through demonstration waivers, the development of Medicare prospective payment systems for many providers, and the implementation of the first quantitative quality measures for managed care plans. His work at HCFA was recognized in 1995 by a National Public Service Award. From 1998 to 1999 he served as a presidential appointee to the National Bipartisan Commission on the Future of Medicare.

After leaving HCFA, Dr. Vladeck spent 6 years as senior vice president for policy and as professor of health policy and geriatrics at Mount Sinai Medical Center in New York City. His assignments there ranged from managing the medical school’s affiliation with New York’s public hospital system to acting as interim chair of the department of geriatrics.

He served as interim president of the University of Medicine and Dentistry of New Jersey, which had lost its academic accreditation. During his 16-month tenure, he restored fiscal stability to the system; rebuilt its governance, compliance, and internal control processes; and laid the groundwork for restoration of its accreditation.

A graduate of Harvard College and the University of Michigan, Dr. Vladeck has held full-time faculty positions at Columbia University and Mount Sinai and has served as adjunct faculty at several institutions. He is a member of the Institute of Medicine and the New York Academy of Medicine and serves on the boards of the Medicare Rights Center, a nonprofit consumer service organization; Ascension Health; and the New York City Board of Health.

Notes

[1] ASN gratefully acknowledges the Northwest Kidney Centers and its contributors for support of the Christopher R. Blagg Endowed Lectureship in Renal Disease and Public Policy.

October-November 2012 (Vol 4, Number 10 &11)